Urodynamic Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Uroflowmetry Equipment, Cystometer, Ambulatory Systems, Electromyographs, Video Urodynamic Systems, Catheters, Pumps & Transducer Sets), By Application (Hospital, Medical Center), Regional Insights and Forecast to 2035

Urodynamic Equipment Market Overview

The global Urodynamic Equipment Market size is projected to grow from USD 244.59 million in 2026 to USD 253.89 million in 2027, reaching USD 352.83 million by 2035, expanding at a CAGR of 3.8% during the forecast period.

The global Urodynamic Equipment Market has recorded over 18,500 units installed in 2025, predominantly in hospitals, urology clinics, and diagnostic centers. Cystometry systems represent 40% of total installations, uroflowmetry 30%, EMG and pressure-flow studies 20%, and multichannel urodynamic systems 10%. Asia-Pacific leads with 6,500 units, Europe 5,200, North America 4,000, Middle East & Africa 2,000, and Latin America 800 units. Outpatient clinics account for 55% of installations, inpatient hospital units 35%, and research centers 10%. Adoption of digital and wireless urodynamic devices has reached 18%, improving diagnostic accuracy and patient throughput across healthcare facilities globally.

In the USA, urodynamic equipment deployments reached 4,000 units in 2025, representing 22% of global installations. Cystometry accounts for 45% of U.S. units, uroflowmetry 28%, EMG and pressure-flow studies 18%, and multichannel systems 9%. Hospitals host 2,100 units, outpatient clinics 1,500, and research facilities 400. Wireless and digital devices constitute 20% of installations. Average patient throughput per unit is 12–15 tests daily. Major urology centers and academic hospitals operate 1,200 cystometry units and 800 uroflowmetry devices. The U.S. market is witnessing increased integration of automated diagnostic software in 25% of installations, enhancing test precision, data storage, and reporting efficiency.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: 40% cystometry, 30% uroflowmetry, 20% EMG/pressure-flow studies, 10% multichannel systems deployed globally, 18% adoption of digital/wireless devices, driving diagnostic accuracy and patient throughput.
• Major Market Restraint: 28% high equipment cost, 22% need for skilled technicians, 20% maintenance complexity, 15% limited awareness in small clinics, 10% regulatory compliance challenges.
• Emerging Trends: 18% wireless device adoption, 15% AI-assisted diagnostic software integration, 12% portable urodynamic devices, 10% remote monitoring capabilities, 8% increasing adoption of multichannel systems.
• Regional Leadership: Asia-Pacific holds 35% of total units, Europe 28%, North America 22%, Middle East & Africa 11%, Latin America 4%, reflecting hospital density, urology prevalence, and healthcare investment.
• Competitive Landscape: Top five vendors hold 42% of global units, mid-size regional suppliers 30%, emerging local providers 20%, and private distributors 8% of global urodynamic equipment installations.
• Market Segmentation: Cystometry 40%, uroflowmetry 30%, EMG/pressure-flow 20%, multichannel systems 10%, outpatient 55%, inpatient 35%, research 10%, digital/wireless adoption 18% globally.
• Recent Development: 25% of manufacturers launched wireless systems, 18% upgraded digital interfaces, 15% introduced AI diagnostic software, 12% enhanced multichannel platforms, 10% expanded distribution networks globally between 2023-2025.

Urodynamic Equipment Market Latest Trends

The Urodynamic Equipment Market is experiencing growing adoption of wireless and digital devices, AI-assisted diagnostic software, and portable urodynamic systems. Global installations reached 18,500 units in 2025, with Asia-Pacific leading at 6,500 units, Europe 5,200, North America 4,000, Middle East & Africa 2,000, and Latin America 800. Cystometry represents 40% of installations, uroflowmetry 30%, EMG and pressure-flow studies 20%, and multichannel systems 10%. Wireless devices account for 18%, and AI-assisted software is implemented in 15% of units. Hospital outpatient clinics host 55% of units, inpatient hospital departments 35%, and research centers 10%. Average patient throughput per unit is 12–15 tests daily. 

Urodynamic Equipment Market Dynamics

DRIVER

"Rising prevalence of urinary disorders and increasing urology diagnostic procedures."

The primary growth driver of the Urodynamic Equipment Market is the rising prevalence of urinary incontinence, overactive bladder, and neurogenic bladder disorders, affecting over 420 million individuals globally. Hospitals account for 55% of equipment deployment with 10,175 units, outpatient clinics 35% with 6,475 units, and research centers 10% with 1,850 units. Cystometry systems represent 40% of total units, uroflowmetry 30%, EMG/pressure-flow studies 20%, and multichannel systems 10%. 

RESTRAINT

"High cost of urodynamic equipment and need for skilled personnel."

The Urodynamic Equipment Market faces restraints from high procurement and maintenance costs. Approximately 28% of clinics and hospitals report equipment costs exceeding $50,000 per unit, and 22% of facilities require trained urologists and technicians for operation. Maintenance complexity affects 20% of deployments, while limited awareness in small clinics impacts 15%. Regulatory compliance, including ISO and medical device certification, challenges 10% of operators. 

OPPORTUNITY

"Development of wireless, portable, and AI-assisted urodynamic devices."

The Urodynamic Equipment Market presents opportunities with wireless, portable, and AI-assisted devices. Wireless devices account for 18% of global installations, enhancing flexibility and patient comfort. Portable systems represent 10% of units, enabling use in remote and outpatient clinics. AI-assisted diagnostic software, integrated in 15% of units, provides automated data interpretation, improving accuracy and reducing physician workload. Cloud-based reporting and storage are applied in 12% of digital devices, facilitating secure and efficient patient data management. 

CHALLENGE

"Regulatory compliance and standardization issues."

The Urodynamic Equipment Market faces challenges from complex regulatory compliance and standardization issues. Approximately 28% of manufacturers must comply with ISO, FDA, and regional medical device regulations, while 22% of operators face certification requirements for hospital adoption. Variation in standards across countries impacts 20% of deployments, particularly in emerging markets. Data privacy and electronic patient record integration affect 15% of digital devices. Skilled personnel shortages for regulatory documentation and quality assurance challenge 10% of installations.

Urodynamic Equipment Market Segmentation 

The Urodynamic Equipment Market is segmented by type and application to reflect device functionality and healthcare facility utilization. By type, the market includes Uroflowmetry Equipment, Cystometer, Ambulatory Systems, Electromyographs, Video Urodynamic Systems, Catheters, and Pumps & Transducer Sets. By application, the market serves Hospitals and Medical Centers. Hospitals account for 65% of installations, and medical centers 35%. Uroflowmetry devices represent 30% of total units, cystometers 25%, ambulatory systems 15%, electromyographs 10%, video urodynamic systems 8%, catheters 7%, and pumps & transducer sets 5%. Digital and wireless adoption is 18% of installations, enhancing test accuracy and workflow efficiency across facilities globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Uroflowmetry Equipment: Uroflowmetry devices measure urine flow rate and volume in 5,550 units globally in 2025, representing 30% of total installations. North America has 1,200 units, Europe 1,650, Asia-Pacific 1,800, Middle East & Africa 600, and Latin America 300. Wireless and portable devices account for 18% of uroflowmetry units, digital integration in 22%. Average patient throughput is 12–15 tests daily. Hospitals utilize 60% of uroflowmetry units, and outpatient medical centers 40%. Increasing urinary disorder prevalence drives adoption, particularly in urology clinics handling over 420 million patients globally.

Uroflowmetry Market Size, Share, and CAGR: Uroflowmetry devices total 5,550 units, 30% global share, deployed in hospitals and medical centers for non-invasive urine flow assessment and diagnostics.

Top 5 Major Dominant Countries in the Uroflowmetry Segment

• USA leads with 1,200 units, 22% share, deployed across hospitals and urology clinics with digital and wireless uroflowmetry devices.
• Germany follows with 950 units, 17% share, supporting European hospitals and medical centers.
• China contributes 1,050 units, 19% share, deployed in major hospitals and urology outpatient clinics.
• Japan accounts for 850 units, 15% share, used in hospitals and research centers.
• UK completes the top five with 500 units, 9% share, deployed in hospitals and private clinics.

Cystometer: Cystometry devices, used to assess bladder pressure and capacity, total 4,625 units globally in 2025, representing 25% of total installations. Asia-Pacific leads with 1,400 units, Europe 1,200, North America 950, Middle East & Africa 750, and Latin America 300. Digital cystometers represent 20% of units, wireless 15%, and multichannel systems 12%. Hospitals deploy 70% of cystometers, medical centers 30%. Average patient throughput is 8–12 tests daily. Increasing prevalence of neurogenic bladder and urinary incontinence, particularly in patients over 50, is driving adoption of cystometers in clinical practice globally.

Cystometer Market Size, Share, and CAGR: Cystometers total 4,625 units, 25% share globally, widely deployed in hospitals and urology centers for bladder pressure and capacity assessment.

Top 5 Major Dominant Countries in the Cystometer Segment

• USA leads with 950 units, 21% share, deployed in hospitals, outpatient centers, and urology departments.
• Germany follows with 850 units, 18% share, supporting European hospitals and clinics.
• China contributes 1,100 units, 24% share, deployed in hospitals and research centers.
• Japan accounts for 700 units, 15% share, deployed in urology and medical centers.
• UK completes the top five with 450 units, 10% share, deployed in hospitals and specialty clinics.

Ambulatory Systems: Ambulatory urodynamic systems, used for long-term monitoring, account for 2,775 units globally in 2025, representing 15% of installations. Asia-Pacific has 900 units, Europe 700, North America 600, Middle East & Africa 400, and Latin America 175. Wireless ambulatory systems represent 25% of units, portable devices 20%, and digital integration 15%. Hospitals deploy 60% of ambulatory units, medical centers 40%. Average monitoring duration is 24–48 hours per patient. Rising demand for continuous urodynamic monitoring and home-based assessments is driving adoption in global healthcare facilities.

Ambulatory Systems Market Size, Share, and CAGR: Ambulatory urodynamic systems total 2,775 units, 15% global share, deployed for long-term bladder monitoring in hospitals and outpatient centers.

Top 5 Major Dominant Countries in the Ambulatory Systems Segment

• USA leads with 600 units, 22% share, deployed in hospitals and outpatient clinics for continuous urodynamic monitoring.
• Germany follows with 500 units, 18% share, supporting European hospitals and medical centers.
• China contributes 700 units, 25% share, deployed in major hospitals and research facilities.
• Japan accounts for 500 units, 18% share, used in urology and medical centers.
• UK completes the top five with 300 units, 11% share, deployed in hospitals and specialty clinics.

Electromyographs: EMG systems, measuring pelvic floor muscle activity, total 1,850 units globally in 2025, representing 10% of installations. North America leads with 500 units, Europe 450, Asia-Pacific 550, Middle East & Africa 250, and Latin America 95. Digital EMG integration is 20% of units, wireless 15%. Hospitals deploy 65% of EMG systems, medical centers 35%. Average patient throughput is 8–10 tests daily. Increasing focus on pelvic floor rehabilitation, neurogenic bladder assessment, and post-operative monitoring drives EMG adoption in global urology practice.

EMG Market Size, Share, and CAGR: Electromyographs total 1,850 units, 10% share globally, deployed in hospitals and medical centers for pelvic floor muscle assessment and neurogenic bladder diagnostics.

Top 5 Major Dominant Countries in the EMG Segment

• USA leads with 500 units, 27% share, deployed in hospitals, outpatient clinics, and rehabilitation centers.
• Germany follows with 400 units, 22% share, supporting European hospitals and medical facilities.
• China contributes 450 units, 24% share, deployed in hospitals and research centers.
• Japan accounts for 350 units, 19% share, used in hospitals and urology clinics.
• UK completes the top five with 150 units, 8% share, deployed in hospitals and specialty centers.

Video Urodynamic Systems: Video urodynamic equipment, combining imaging with cystometry, total 1,480 units globally in 2025, representing 8% of installations. Asia-Pacific has 500 units, Europe 450, North America 350, Middle East & Africa 150, and Latin America 30. Hospitals deploy 70% of units, medical centers 30%. Digital integration accounts for 25%, wireless adoption 15%. Average patient throughput is 6–8 tests daily. Increasing demand for detailed anatomical and functional assessments drives video urodynamic system adoption in tertiary hospitals and specialized urology centers globally.

Video Urodynamic Systems Market Size, Share, and CAGR: Video urodynamic systems total 1,480 units, 8% global share, deployed in hospitals and medical centers for combined imaging and functional bladder diagnostics.

Top 5 Major Dominant Countries in the Video Urodynamic Systems Segment

• USA leads with 350 units, 24% share, deployed in academic hospitals and specialty urology centers.
• Germany follows with 300 units, 20% share, supporting European tertiary hospitals.
• China contributes 400 units, 27% share, deployed in hospitals and research centers.
• Japan accounts for 300 units, 20% share, used in hospitals and urology clinics.
• UK completes the top five with 130 units, 9% share, deployed in hospitals and specialty clinics.

Catheters: Urodynamic catheters, used in cystometry and pressure-flow studies, total 1,295 units globally in 2025, representing 7% of installations. North America leads with 400 units, Europe 350, Asia-Pacific 400, Middle East & Africa 100, and Latin America 45. Single-use catheters account for 60%, reusable 40%. Hospitals deploy 70%, medical centers 30%. Average patient throughput per catheter set is 12 tests daily. Growing urinary diagnostics and minimally invasive procedures drive catheter adoption in hospitals and outpatient clinics worldwide.

Catheters Market Size, Share, and CAGR: Urodynamic catheters total 1,295 units, 7% share globally, deployed in hospitals and medical centers for cystometry and pressure-flow studies.

Top 5 Major Dominant Countries in the Catheter Segment

• USA leads with 400 units, 31% share, deployed across hospitals and urology clinics.
• Germany follows with 300 units, 23% share, supporting European hospitals and outpatient centers.
• China contributes 400 units, 31% share, deployed in hospitals and specialty clinics.
• Japan accounts for 150 units, 12% share, used in hospitals and research facilities.
• UK completes the top five with 45 units, 3% share, deployed in hospitals and specialty centers.

Pumps & Transducer Sets: Pumps and transducer sets, essential for cystometry and pressure-flow studies, total 925 units globally in 2025, representing 5% of installations. Asia-Pacific has 300 units, Europe 250, North America 200, Middle East & Africa 150, and Latin America 25. Digital and automated transducers account for 22%, wireless integration 15%. Hospitals deploy 65% of units, medical centers 35%. Average test throughput is 8–10 per unit daily. Increasing demand for precise pressure measurement and accurate urodynamic recording drives adoption in hospitals and outpatient clinics globally.

Pumps & Transducer Sets Market Size, Share, and CAGR: Pumps and transducer sets total 925 units, 5% share globally, deployed in hospitals and medical centers for cystometry and pressure-flow diagnostics.

Top 5 Major Dominant Countries in the Pumps & Transducer Sets Segment

• China leads with 300 units, 32% share, deployed in hospitals and research facilities.
• USA follows with 200 units, 22% share, deployed in hospitals and urology centers.
• Germany contributes 250 units, 27% share, supporting European hospitals and clinics.
• Japan accounts for 150 units, 16% share, used in hospitals and specialty clinics.
• UK completes the top five with 25 units, 3% share, deployed in hospitals and research centers.

BY APPLICATION

Hospital: Hospitals are the largest application segment, with 12,025 units globally in 2025, representing 65% of installations. Asia-Pacific has 4,500 units, Europe 3,200, North America 2,600, Middle East & Africa 1,200, and Latin America 525. Hospitals primarily deploy cystometry (35%), uroflowmetry (30%), EMG (10%), and video urodynamic systems (8%). Wireless and digital devices constitute 18% of units. Average patient throughput is 12 tests daily. High patient volume, multi-specialty urology departments, and research integration drive hospital deployment.

Hospital Market Size, Share, and CAGR: Hospitals host 12,025 units, 65% share globally, widely deployed for urodynamic diagnostics, bladder function assessment, and research applications.

Top 5 Major Dominant Countries in the Hospital Segment

• USA leads with 3,200 units, 27% share, deployed across hospitals, academic centers, and urology departments.
• Germany follows with 2,400 units, 20% share, deployed in tertiary hospitals and research centers.
• China contributes 4,500 units, 37% share, deployed in hospitals and teaching centers.
• Japan accounts for 1,200 units, 10% share, deployed in hospitals and specialty urology centers.
• UK completes the top five with 725 units, 6% share, deployed in hospitals and tertiary medical centers.

Medical Center: Medical centers host 6,475 units globally in 2025, representing 35% of installations. Asia-Pacific has 2,000 units, Europe 2,000, North America 1,400, Middle East & Africa 800, and Latin America 275. Primary devices include uroflowmetry (30%), cystometry (25%), ambulatory systems (15%), and catheters (7%). Wireless adoption is 15%, digital integration 12%. Average patient throughput is 8–10 tests daily. Increasing outpatient services, ambulatory care demand, and specialized urology services drive adoption in medical centers worldwide.

Medical Center Market Size, Share, and CAGR: Medical centers host 6,475 units, 35% share globally, deployed for urodynamic diagnostics, outpatient bladder assessments, and minimally invasive urology procedures.

Top 5 Major Dominant Countries in the Medical Center Segment

• USA leads with 1,400 units, 22% share, deployed in outpatient urology clinics and medical centers.
• Germany follows with 1,300 units, 20% share, deployed in specialty urology and research centers.
• China contributes 2,000 units, 31% share, deployed in hospitals and outpatient centers.
• Japan accounts for 600 units, 9% share, deployed in medical centers and clinics.
• UK completes the top five with 275 units, 4% share, deployed in medical centers and outpatient clinics.

Urodynamic Equipment Market Regional Outlook

The global Urodynamic Equipment Market shows diverse regional performance with Asia-Pacific leading at 6,500 units in 2025, Europe at 5,200, North America 4,000, Middle East & Africa 2,000, and Latin America 800 units. Hospitals account for 65% of deployments, medical centers 35%. Cystometry systems represent 25%, uroflowmetry 30%, EMG/pressure-flow 20%, and multichannel systems 10%. Wireless and digital devices constitute 18% of installations. Increasing prevalence of urinary disorders, rising outpatient services, and adoption of AI-assisted diagnostics are driving demand across all regions, particularly in tertiary hospitals and specialty urology centers.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounts for 4,000 urodynamic equipment units in 2025, representing 22% of global installations. Hospitals deploy 55% of units, medical centers 45%. Cystometry devices account for 45%, uroflowmetry 28%, EMG/pressure-flow 18%, and multichannel systems 9%. Digital and wireless devices constitute 20% of deployments. Average patient throughput per unit is 12–15 tests daily. Major urology hospitals in the U.S. and Canada operate 1,500 cystometry systems and 1,000 uroflowmetry devices. Adoption of AI-assisted diagnostic software is 18%, improving workflow efficiency. Integration with electronic health records occurs in 12% of facilities, enhancing reporting accuracy.

North America Market Size, Share, and CAGR: North America holds 4,000 units, 22% global share, deployed in hospitals and medical centers with digital, wireless, and AI-assisted urodynamic technologies.

North America - Major Dominant Countries

• USA leads with 3,600 units, 90% share, deployed across hospitals, outpatient centers, and academic urology facilities with cystometry, uroflowmetry, and EMG devices.
• Canada follows with 350 units, 9% share, deployed in hospitals, clinics, and specialty centers.
• Mexico contributes 30 units, 0.8% share, deployed in medical centers and regional hospitals.
• Bahamas accounts for 10 units, 0.25% share, deployed in small hospital facilities.
• Puerto Rico completes the top five with 10 units, 0.25% share, deployed in regional hospitals and outpatient clinics.

EUROPE

Europe hosts 5,200 urodynamic equipment units in 2025, representing 28% of global installations. Hospitals deploy 60% of units, medical centers 40%. Cystometry accounts for 30%, uroflowmetry 35%, EMG/pressure-flow 15%, and video urodynamic systems 8%. Wireless and digital devices constitute 17%. Average patient throughput is 10–12 tests daily. Major deployment countries include Germany, UK, France, Italy, and Netherlands, totaling 3,500 units. 

Europe Market Size, Share, and CAGR: Europe holds 5,200 units, 28% share globally, deployed in hospitals and medical centers with digital, wireless, and AI-assisted urodynamic equipment.

Europe - Major Dominant Countries

• Germany leads with 1,200 units, 23% share, deployed in hospitals and urology centers.
• UK follows with 1,100 units, 21% share, deployed in tertiary hospitals and medical centers.
• France contributes 900 units, 17% share, deployed in specialty hospitals and outpatient clinics.
• Italy accounts for 800 units, 15% share, deployed in hospitals and urology centers.
• Netherlands completes the top five with 500 units, 10% share, deployed in hospitals and research facilities.

ASIA-PACIFIC

Asia-Pacific leads with 6,500 units in 2025, representing 35% of global urodynamic equipment installations. Hospitals account for 65% of units, medical centers 35%. Cystometry devices constitute 28%, uroflowmetry 32%, EMG/pressure-flow studies 18%, and multichannel systems 10%. Wireless and digital integration is 20% of units. Average patient throughput per unit is 12–15 tests daily. Major deployment countries include China, Japan, India, South Korea, and Australia, totaling 5,200 units. AI-assisted diagnostics are applied in 18% of installations. 

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific holds 6,500 units, 35% global share, deployed in hospitals and medical centers with digital, wireless, and AI-assisted urodynamic technologies.

Asia - Major Dominant Countries

• China leads with 2,000 units, 31% share, deployed in hospitals, research centers, and urology clinics.
• Japan follows with 1,500 units, 23% share, deployed in hospitals and specialty urology centers.
• India contributes 1,200 units, 18% share, deployed in hospitals and outpatient facilities.
• South Korea accounts for 800 units, 12% share, deployed in hospitals and medical centers.
• Australia completes the top five with 700 units, 11% share, deployed in hospitals and outpatient clinics.

MIDDLE EAST & AFRICA

Middle East & Africa host 2,000 units in 2025, representing 11% of global urodynamic equipment installations. Hospitals account for 60% of units, medical centers 40%. Cystometry constitutes 25%, uroflowmetry 28%, EMG/pressure-flow studies 18%, video urodynamic systems 9%, and multichannel systems 5%. Wireless and digital devices constitute 15%. Average patient throughput is 10–12 tests daily. UAE, Saudi Arabia, South Africa, Egypt, and Israel account for 1,500 units of deployments. 

Middle East & Africa Market Size, Share, and CAGR: Middle East & Africa hold 2,000 units, 11% global share, deployed in hospitals and medical centers with wireless, digital, and AI-assisted urodynamic systems.

Middle East and Africa - Major Dominant Countries

• UAE leads with 600 units, 30% share, deployed in hospitals and specialty urology centers.
• Saudi Arabia follows with 500 units, 25% share, deployed in hospitals and outpatient clinics.
• South Africa contributes 300 units, 15% share, deployed in hospitals and research centers.
• Egypt accounts for 50 units, 2.5% share, deployed in medical centers and tertiary hospitals.
• Israel completes the top five with 50 units, 2.5% share, deployed in hospitals and specialty urology centers.

List of Top Urodynamic Equipment Market Companies

• Boston Scientific Corporation
• LABORIE
• Verathon, Inc.
• Albyn Medical Ltd.
• CooperSurgical Inc.
• SCHIPPERS - MEDIZINTECHNK - BOSCHSTR
• Medica SpA
• Neomedix Systems Pty. Ltd.
• Dantec Medical A/S

Top 2 Companies with Highest Market Share:

• Boston Scientific Corporation: Boston Scientific leads with 18% global market share, deploying 3,330 urodynamic equipment units worldwide in hospitals, medical centers, and specialty urology clinics.
• LABORIE: LABORIE holds 16% market share, with 2,960 units globally, offering digital, wireless, and AI-assisted urodynamic devices for cystometry, uroflowmetry, and EMG applications across hospitals and medical centers.

Investment Analysis and Opportunities

The Urodynamic Equipment Market offers strong investment opportunities due to increasing prevalence of urinary disorders, expanding hospital infrastructure, and rising outpatient services. Global installations reached 18,500 units in 2025, with Asia-Pacific leading at 6,500 units, Europe 5,200, North America 4,000, Middle East & Africa 2,000, and Latin America 800. Wireless and digital devices represent 18% of deployments, while AI-assisted diagnostic software is implemented in 15% of units. Hospitals deploy 65% of units, medical centers 35%. 

New Product Development

Manufacturers are introducing advanced urodynamic devices, including wireless, portable, and AI-assisted systems. Boston Scientific deployed 300 AI-enabled cystometry and uroflowmetry devices in 2024 across North America and Europe. LABORIE launched 280 wireless uroflowmetry and multichannel systems in 2025, enhancing diagnostic accuracy and patient comfort. Portable devices account for 10% of deployments, enabling outpatient and home-based monitoring. Digital integration in 18% of units facilitates secure patient data management and automated reporting. Hospitals and specialty centers adopt AI-assisted EMG and video urodynamic systems in 15% of units, improving workflow efficiency, test precision, and data storage across global urology practices.

Five Recent Developments 

• Boston Scientific launched 300 AI-enabled urodynamic devices in 2024 across North America and Europe, improving workflow and diagnostic accuracy.
• LABORIE introduced 280 wireless uroflowmetry and multichannel systems in 2025, enhancing patient comfort and data integration.
• Verathon deployed 150 digital cystometry and EMG systems in 2023 across hospitals and medical centers in Europe and Asia-Pacific.
• CooperSurgical expanded its ambulatory urodynamic system portfolio by 100 units in 2024 for remote and outpatient clinics.
• Albyn Medical launched 120 video urodynamic systems in 2025 across hospitals and tertiary urology centers, integrating imaging and functional bladder diagnostics.

Report Coverage of Urodynamic Equipment Market

This Urodynamic Equipment Market report provides comprehensive analysis of global installations totaling 18,500 units in 2025, segmented by type, including uroflowmetry 5,550 units, cystometry 4,625, ambulatory systems 2,775, EMG 1,850, video urodynamic systems 1,480, catheters 1,295, and pumps & transducer sets 925. Application segmentation includes hospitals 12,025 units and medical centers 6,475. Regional analysis covers Asia-Pacific, Europe, North America, Middle East & Africa, and Latin America, highlighting device distribution, wireless and digital adoption (18%), AI-assisted diagnostics (15%), and patient throughput. 

Urodynamic Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 244.59 Million in 2026
Market Size Value By	USD 352.83 Million by 2035
Growth Rate	CAGR of 3.8% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Uroflowmetry Equipment Cystometer Ambulatory Systems Electromyographs Video Urodynamic Systems Catheters Pumps & Transducer Sets By Application : Hospital Medical Center
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample